Table 4. Tumour control rates according to serum levels of IL-6 and IL-1β in patients with gemcitabine monotherapy for advanced pancreatic cancer.
IL-6/IL-1β classification | N | Median (95% CI) (%) | P-value |
---|---|---|---|
IL-6Low/IL-1βLow |
25 |
76.0 (56.6–88.5) |
Ref. |
IL-6Low/IL-1βHigh |
5 |
60.0 (23.1–88.2) |
0.589 |
IL-6High/IL-1βLow |
15 |
40.0 (19.8–64.3) |
0.042 |
IL-6High/IL-1βHigh | 15 | 20.0 (7.0–45.2) | <0.001 |
Abbreviations: CI=confidence interval; IL=interleukin.